Skip to content ↓

Latest bone marrow drive nets 201 potential donors

The second bone marrow registration drive at MIT in three months attracted 201 minority students, staff and faculty, hoping that one of them would be a match for former MIT student David Li, who is suffering from leukemia. A November drive set a single-day minority drive record with 463 registrants.
Last Friday's drive concentrated on Asians, Pacific Islanders, Africans, Hispanics, Native Americans and persons of mixed ethnicity because of the shortage of donors from those groups. A patient needing a bone marrow transplant is more likely to match with someone from his or her own ethnic group.

Prospective donors registered in the Bush Room from 10am-6pm and gave a small blood sample, which will be tested to determine the person's human leukocyte antigen (HLA). The results will be added to the National Marrow Donors Program international database, which is searched on behalf of patients who need a transplant. About 3,000 persons search for a match each day.

Susan Dacy, a graduate resident tutor at Burton-Conner, acted as liaison for the event.

For additional information, e-mail contactmarrow@mit.edu or call the Cammy Lee Leukemia Foundation at 1-800-77-CAMMY.

A version of this article appeared in MIT Tech Talk on March 1, 2000.

Related Topics

More MIT News

Rich Nielsen, Volha Charnysh, Kevin Dorst, and Emily Richmond Pollock seated at a table, talking

Building a scholarly community

The SHASS Faculty Fellows Program, administered by the MIT Human Insight Collaborative, is fostering new research projects and creating space for supportive and interdisciplinary discussion.

Read full story

Globular blue and white orbs "examining" single-stranded RNA products and marking them with green checks or red x's

Why are some bacterial genes high in purines?

In certain species of bacteria, the answer lies in shielding RNA transcripts from a quality-control factor called Rho. Understanding the requirements for expressible sequences is critical for expression engineering of therapeutic agents.

Read full story